The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees

BACKGROUND: Aromatase inhibitors (AIs) substantially reduce breast cancer mortality in clinical trials, but high rates of nonadherence to these long-term oral therapies have reduced their impact outside of trials. We examined the association of generic AI availability with AI adherence among a large...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Autores principales: Neuner, Joan M., Kamaraju, Sailaja, Charlson, John A., Wozniak, Erica M., Smith, Elizabeth C., Biggers, Alana, Smallwood, Alicia J., Laud, Purushottam W., Pezzin, Liliana E.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580559/
https://ncbi.nlm.nih.gov/pubmed/25971298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares